ROG: Rogers Corp.
About
Rogers Corp. engages in the design, development, manufacture, and sale of engineered materials and components for mission critical applications. It operates through the following segments: Advanced Electronics Solutions (AES) and Elastomeric Material Solutions (EMS), and Other. The AES segment manufactures and sells circuit materials, ceramic substrate materials, busbars and cooling solutions for applications in electric and hybrid electric vehicles, wireless infrastructure, automotive, telematics and thermal solutions, aerospace and defense, mass transit, clean energy, connected devices and wired infrastructures. The EMS segment consists of elastomeric material solutions for critical cushioning, gasketing and sealing, impact protection, and vibration management applications. The Other segment consists of elastomer components for applications in ground transportation, office equipment, consumer and other markets. The company was founded by Peter Rogers in 1832 and is headquartered in Chandler, AZ.
Current Value
$106.251 Year Return
Current Value
$106.251 Year Return
Key Details
Market Cap
$1.97B
P/E Ratio
39.51
1Y Stock Return
-18.47%
1Y Revenue Growth
-9.17%
Dividend Yield
0.00%
Price to Book
1.5
Strategies that include ROG
Stock's related to ROG
Correlated Stocks
| Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
|---|---|---|---|---|
| SCL | 63.61% | $1.69B | -12.82% | 2.01% |
| NOVT | 61.82% | $6.05B | +14.71% | 0.00% |
| KWR | 60.84% | $2.79B | -16.68% | 1.18% |
| MTX | 60.71% | $2.63B | +31.19% | 0.50% |
| CTS | 60.64% | $1.67B | +40.33% | 0.29% |
| AVNT | 60.28% | $4.69B | +45.81% | 2.01% |
| KN | 60.26% | $1.75B | +24.00% | 0.00% |
| MOG.A | 59.64% | $6.98B | +54.81% | 0.51% |
| LFUS | 59.22% | $6.11B | +2.69% | 1.10% |
| NPO | 59.19% | $4.02B | +45.17% | 0.47% |
| KFRC | 59.15% | $1.17B | -3.64% | 0.62% |
| KALU | 58.88% | $1.33B | +41.69% | 3.70% |
| ALG | 58.43% | $2.41B | +7.83% | 0.52% |
| TROW | 58.30% | $27.42B | +22.75% | 4.00% |
| AIN | 58.20% | $2.60B | -5.33% | 1.26% |
| VSH | 57.99% | $2.51B | -17.12% | 2.65% |
| AN | 57.85% | $7.15B | +33.47% | 0.00% |
| IOSP | 57.64% | $2.98B | +10.26% | 1.31% |
| AEIS | 57.62% | $4.45B | +25.19% | 0.34% |
| FLS | 57.36% | $8.09B | +61.04% | 1.35% |
Uncorrelated Stocks
| Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
|---|---|---|---|---|
| ED | 0.03% | $33.79B | +6.95% | 3.44% |
| EDSA | 0.06% | $7.92M | -30.29% | 0.00% |
| RLMD | -0.15% | $83.58M | +10.80% | 0.00% |
| NXTC | 0.15% | $31.65M | -5.03% | 0.00% |
| NHTC | -0.15% | $61.13M | -1.12% | 14.95% |
| JNJ | -0.17% | $366.82B | -3.90% | 3.25% |
| PRAX | 0.20% | $1.34B | +307.86% | 0.00% |
| ALNY | 0.23% | $32.48B | +47.82% | 0.00% |
| CPSH | 0.27% | $21.35M | -37.97% | 0.00% |
| QNRX | -0.52% | $4.14M | -83.35% | 0.00% |
| PEP | 0.52% | $221.85B | -3.72% | 2.48% |
| PRPH | -0.54% | $18.52M | -83.84% | 0.00% |
| SO | 0.64% | $94.51B | +21.61% | 3.32% |
| WM | 0.74% | $90.31B | +30.01% | 1.00% |
| RSG | 0.76% | $67.26B | +33.03% | 1.02% |
| PSTX | -0.76% | $909.35M | +212.04% | 0.00% |
| DXCM | 0.80% | $31.60B | -30.96% | 0.00% |
| MANU | 0.84% | $2.86B | -14.18% | 0.00% |
| BCAN | 0.89% | $73.19M | -99.72% | 0.00% |
| IFRX | 1.02% | $132.49M | +60.71% | 0.00% |
Inversely Correlated Stocks
| Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
|---|---|---|---|---|
| CBOE | -28.59% | $22.21B | +16.58% | 1.12% |
| HUSA | -12.90% | $17.27M | -24.57% | 0.00% |
| MCK | -12.46% | $78.44B | +34.11% | 0.43% |
| PGR | -12.35% | $153.84B | +60.59% | 0.44% |
| COR | -11.99% | $48.33B | +22.74% | 0.83% |
| MNR | -11.99% | $1.60B | -13.75% | 20.73% |
| NOC | -10.86% | $70.69B | +1.80% | 1.67% |
| NEUE | -10.50% | $43.50M | -19.66% | 0.00% |
| ABBV | -10.38% | $320.74B | +25.54% | 3.44% |
| CHD | -10.11% | $26.94B | +17.62% | 1.04% |
| PRPO | -8.68% | $8.75M | -7.66% | 0.00% |
| LTM | -7.90% | $8.23B | -100.00% | <0.01% |
| QTTB | -7.70% | $301.59M | +152.40% | 0.00% |
| CPB | -7.58% | $13.55B | +12.78% | 3.44% |
| KNSL | -7.36% | $11.64B | +46.38% | 0.12% |
| STG | -7.30% | $33.21M | -25.59% | 0.00% |
| BTCT | -7.22% | $60.85M | +288.68% | 0.00% |
| CME | -6.84% | $86.75B | +13.02% | 1.90% |
| LMT | -6.72% | $122.55B | +15.86% | 2.48% |
| MNOV | -6.39% | $112.81M | +32.18% | 0.00% |
ETF's related to ROG
Correlated ETFs
| Name | Correlation | AUM | Expense Ratio |
|---|---|---|---|
| EFAA | 70.36% | $105.52M | 0% |
| IJR | 68.95% | $94.51B | 0.06% |
| DFAT | 68.71% | $11.61B | 0.28% |
| SPSM | 68.66% | $13.34B | 0.03% |
| GSSC | 68.60% | $553.05M | 0.2% |
| DFSV | 68.53% | $4.36B | 0.31% |
| VIOO | 68.53% | $3.31B | 0.1% |
| VXF | 68.50% | $22.81B | 0.06% |
| IJT | 68.32% | $6.97B | 0.18% |
| EES | 68.22% | $696.65M | 0.38% |
| PRFZ | 68.13% | $2.75B | 0.39% |
| SLYV | 68.01% | $4.31B | 0.15% |
| SLYG | 67.96% | $3.91B | 0.15% |
| VTWO | 67.95% | $13.16B | 0.1% |
| VIOV | 67.89% | $1.52B | 0.15% |
| IWM | 67.86% | $80.66B | 0.19% |
| JMEE | 67.75% | $1.61B | 0.24% |
| IJS | 67.73% | $7.69B | 0.18% |
| PSC | 67.64% | $743.92M | 0.38% |
| FYX | 67.60% | $1.02B | 0.6% |
Uncorrelated ETFs
| Name | Correlation | AUM | Expense Ratio |
|---|---|---|---|
| GBIL | -0.15% | $5.68B | 0.12% |
| IBTE | -0.24% | $1.64B | 0.07% |
| BILZ | -0.48% | $541.42M | 0.14% |
| BOXX | -0.85% | $4.45B | 0.1949% |
| ULST | 0.96% | $537.59M | 0.2% |
| MINT | 1.03% | $11.69B | 0.35% |
| XBIL | -1.46% | $633.44M | 0.15% |
| CSHI | 1.61% | $493.76M | 0.38% |
| XHLF | -1.87% | $900.10M | 0.03% |
| HDRO | -1.94% | $164.26M | 0.3% |
| CORN | -2.02% | $59.94M | 0.2% |
| XONE | 2.16% | $550.19M | 0.03% |
| CCOR | -2.53% | $110.21M | 1.18% |
| AGZD | 2.91% | $132.76M | 0.23% |
| SHV | 3.49% | $18.61B | 0.15% |
| TBIL | -3.64% | $4.42B | 0.15% |
| SGOV | 3.68% | $27.99B | 0.09% |
| IVOL | 3.76% | $504.55M | 1.02% |
| DBE | 4.04% | $50.22M | 0.77% |
| KMLM | -4.13% | $344.74M | 0.9% |
Inversely Correlated ETFs
| Name | Correlation | AUM | Expense Ratio |
|---|---|---|---|
| BTAL | -53.49% | $365.42M | 1.43% |
| VIXY | -35.51% | $195.31M | 0.85% |
| TAIL | -26.35% | $68.19M | 0.59% |
| USDU | -17.91% | $210.52M | 0.5% |
| UUP | -14.70% | $376.91M | 0.77% |
| CTA | -11.22% | $367.83M | 0.76% |
| JUCY | -9.79% | $325.86M | 0.6% |
| WEAT | -7.32% | $119.27M | 0.28% |
| SHYD | -6.94% | $312.98M | 0.35% |
| EQLS | -6.58% | $8.93M | 1% |
| KCCA | -6.00% | $219.07M | 0.87% |
| BSCO | -5.67% | $2.27B | 0.1% |
| CLOI | -5.26% | $749.05M | 0.4% |
| UNG | -5.00% | $856.92M | 1.06% |
| KMLM | -4.13% | $344.74M | 0.9% |
| TBIL | -3.64% | $4.42B | 0.15% |
| CCOR | -2.53% | $110.21M | 1.18% |
| CORN | -2.02% | $59.94M | 0.2% |
| HDRO | -1.94% | $164.26M | 0.3% |
| XHLF | -1.87% | $900.10M | 0.03% |
News
Fintel
Rogers (ROG) Price Target Decreased by 14.38% to 127.50
Yahoo
What trends should we look for it we want to identify stocks that can multiply in value over the long term? Amongst...
Yahoo
Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that it has received CE Mark for its VENTANA® FOLR1 (FOLR1-2.1) RxDx Assay. This is the first immunohistochemistry (IHC) companion diagnostic test to be made widely available in Europe to aid in identifying epithelial ovarian cancer (EOC) patients who may be eligible for targeted treatment with ELAHERE® (mirvetuximab soravtansine). ELAHERE is a first-in-class antibody-drug conjugate (ADC) therapy developed by AbbVie for the treatment of FRɑ-posi
Yahoo
The subdued market reaction suggests that Rogers Corporation's ( NYSE:ROG ) recent earnings didn't contain any...
Yahoo
Rogers ( NYSE:ROG ) Third Quarter 2024 Results Key Financial Results Revenue: US$210.3m (down 8.2% from 3Q 2023). Net...
Yahoo
Q3 2024 Rogers Corp Earnings Call
Disclaimer
Information on this page is obtained from our data provider, Xignite, an unaffiliated third party. Double believes the information shown here is reliable, but has not been verified and there is no guarantee that the information is accurate. We also show information based on calculations performed by Double using data from our provider. Double believes this information is reliable, but has not verified the data and there is no guarantee that the calculations are accurate.